Showing results (1-10 of 526) with videos related to
Sort By:
Pageof 53
Cancer|August 15, 1984
Tamoxifen in advanced prostatic carcinoma. A dose escalation studyF M Torti, B L Lum, R Lo, et al.The Journal of Urology|July 1, 1991
Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasionS Kaubisch, B L Lum, J Reese, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Superficial bladder cancer: the primacy of grade in the development of invasive diseaseF M Torti, B L Lum, D Aston, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1984
The biology and treatment of superficial bladder cancerF M Torti, B L LumCancer|February 1, 1987
Superficial bladder cancer. Risk of recurrence and potential role for interferon therapyF M Torti, B L LumJournal of the National Cancer Institute|May 15, 1991
Adjuvant intravesicular pharmacotherapy for superficial bladder cancerB L Lum, F M TortiSeminars in Oncology|September 1, 1986
Superficial carcinoma of the bladder: natural history and the role of interferonsF M Torti, B L LumThe Journal of Urology|February 1, 1996
A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancerF Freiha, J Reese, F M TortiCancer Treatment Reviews|December 1, 1985
Therapeutic approaches including interferon to carcinoma in situ of the bladderB L Lum, F M TortiJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Weekly doxorubicin in endocrine-refractory carcinoma of the prostateF M Torti, D Aston, B L Lum, et al.Pageof 53